114 related articles for article (PubMed ID: 8392344)
1. Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus.
Ozaki Y; Jinnai Y; Yatomi Y; Tawata M; Onaya T; Kume S
Arzneimittelforschung; 1993 May; 43(5):536-9. PubMed ID: 8392344
[TBL] [Abstract][Full Text] [Related]
2. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
3. Effects of dilazep (AS-05) on human blood platelet aggregation.
Kuzuya F
Arzneimittelforschung; 1979; 29(3):539-42. PubMed ID: 582740
[TBL] [Abstract][Full Text] [Related]
4. [The effect of dilazep on circulating platelet aggregation in diabetics].
Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
[TBL] [Abstract][Full Text] [Related]
5. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
[TBL] [Abstract][Full Text] [Related]
6. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia.
Hiramatsu K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Jan; 6(1):49-57. PubMed ID: 7256794
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the effect of dilazep and dipyridamole on some platelet functions.
Valori VM; Leone G; Traisci G; Bizzi B
Arzneimittelforschung; 1982; 32(4):403-5. PubMed ID: 7201810
[TBL] [Abstract][Full Text] [Related]
8. Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation.
Colli S; Maderna P; Morazzoni G; Speroni C; Tremoli E
Pharmacol Res Commun; 1983 Jun; 15(6):593-602. PubMed ID: 6412253
[TBL] [Abstract][Full Text] [Related]
9. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes.
Michno A; Bielarczyk H; Pawełczyk T; Jankowska-Kulawy A; Klimaszewska J; Szutowicz A
Diabetes; 2007 Feb; 56(2):462-7. PubMed ID: 17259392
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
11. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
[TBL] [Abstract][Full Text] [Related]
12. [Studies on platelets in diabetic patients. Part 1: Platelet aggregation, volume and microviscosity in diabetes mellitus treated with diet, antidiabetic agent and insulin (author's transl)].
Hiramatsu K; Nozaki H; Arimori S
Rinsho Ketsueki; 1981 Jun; 22(6):844-8. PubMed ID: 6801298
[No Abstract] [Full Text] [Related]
13. [The effect of cephalexin on thrombocyte function in diabetics and normal persons].
Peters KM; Reuter HD
Arzneimittelforschung; 1987 Jul; 37(7):843-6. PubMed ID: 3675681
[TBL] [Abstract][Full Text] [Related]
14. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.
Rao AK; Goldberg RE; Walsh PN
J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642
[TBL] [Abstract][Full Text] [Related]
15. [Thrombocyte migration test--method, value and reproducibility].
Sinzinger H; Kaliman J; Joskowicz G
Wien Klin Wochenschr; 1983 Nov; 95(22):792-6. PubMed ID: 6670277
[TBL] [Abstract][Full Text] [Related]
16. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
[TBL] [Abstract][Full Text] [Related]
17. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
[TBL] [Abstract][Full Text] [Related]
18. [Modulation of platelet tyrosine phosphatases by arachidonic acid metabolites in diabetes mellitus complicated with acute pyogenic inflammation].
Barinova ME
Patol Fiziol Eksp Ter; 2010; (2):23-6. PubMed ID: 20804071
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
